In the BioHarmony Drug Report Database

"Preview" Icon

Fluoxetine

Fluoxetine, Prozac, Prozac Weekly, Sarafem (fluoxetine) is a small molecule pharmaceutical. Fluoxetine was first approved as Fluoxetine on 1987-12-29. It is used to treat bulimia, major depressive disorder, obsessive-compulsive disorder, and panic disorder in the USA. The pharmaceutical is active against sodium-dependent serotonin transporter. In addition, it is known to target equilibrative nucleoside transporter 4, 5-hydroxytryptamine receptor 2B, anoctamin-1, potassium voltage-gated channel subfamily C member 1, G protein-activated inward rectifier potassium channel 2, 5-hydroxytryptamine receptor 6, 5-hydroxytryptamine receptor 2A, and 5-hydroxytryptamine receptor 2C.

 

Trade Name

 

Fluoxetine, Prozac, Prozac Weekly, Sarafem
 

Common Name

 

fluoxetine
 

ChEMBL ID

 

CHEMBL41
 

Indication

 

bulimia, major depressive disorder, obsessive-compulsive disorder, panic disorder
 

Drug Class

 

Antidepressants (fluoxetine type)

Image (chem structure or protein)

Fluoxetine structure rendering